Humana Inc. (0J6Z.L)
USD 283.49
(-1.54%)
USD 283.49
(-1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 30.74 Billion USD | 8.44% |
| 2022 | 28.35 Billion USD | -1.01% |
| 2021 | 28.64 Billion USD | 34.17% |
| 2020 | 21.34 Billion USD | 25.54% |
| 2019 | 17 Billion USD | 12.01% |
| 2018 | 15.18 Billion USD | -9.85% |
| 2017 | 16.84 Billion USD | 17.74% |
| 2016 | 14.3 Billion USD | 277.04% |
| 2015 | 3.79 Billion USD | -0.81% |
| 2014 | 3.82 Billion USD | 47.12% |
| 2013 | 2.6 Billion USD | -0.42% |
| 2012 | 2.61 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 33.36 Billion USD | -1.59% |
| 2024 Q3 | 32.38 Billion USD | -2.94% |
| 2024 Q1 | 33.9 Billion USD | 10.89% |
| 2023 Q4 | 30.57 Billion USD | -21.41% |
| 2023 Q3 | 38.9 Billion USD | -1.68% |
| 2023 Q2 | 39.56 Billion USD | 3.73% |
| 2023 FY | 30.57 Billion USD | 7.83% |
| 2023 Q1 | 38.14 Billion USD | 34.52% |
| 2022 Q4 | 28.35 Billion USD | -17.69% |
| 2022 Q2 | 31.31 Billion USD | 1.11% |
| 2022 Q1 | 30.96 Billion USD | 8.1% |
| 2022 FY | 28.35 Billion USD | -1.01% |
| 2022 Q3 | 34.44 Billion USD | 10.02% |
| 2021 Q2 | 23.22 Billion USD | 283.16% |
| 2021 FY | 28.64 Billion USD | 34.17% |
| 2021 Q4 | 28.64 Billion USD | -1.35% |
| 2021 Q3 | 29.03 Billion USD | 25.02% |
| 2021 Q1 | 6.06 Billion USD | 0.03% |
| 2020 Q1 | 6.05 Billion USD | 21.94% |
| 2020 Q3 | 6.05 Billion USD | 0.02% |
| 2020 FY | 21.34 Billion USD | 25.54% |
| 2020 Q4 | 6.06 Billion USD | 0.02% |
| 2020 Q2 | 6.05 Billion USD | 0.02% |
| 2019 Q4 | 4.96 Billion USD | -7.42% |
| 2019 FY | 17 Billion USD | 12.01% |
| 2019 Q3 | 5.36 Billion USD | 22.57% |
| 2019 Q2 | 4.37 Billion USD | 0.02% |
| 2019 Q1 | 4.37 Billion USD | 0.02% |
| 2018 Q2 | 24.05 Billion USD | 404.17% |
| 2018 Q1 | 4.77 Billion USD | -72.47% |
| 2018 FY | 15.18 Billion USD | -9.85% |
| 2018 Q3 | 4.77 Billion USD | -80.16% |
| 2018 Q4 | 4.37 Billion USD | -8.36% |
| 2017 Q2 | 4.27 Billion USD | -10.48% |
| 2017 Q3 | 3.97 Billion USD | -7.06% |
| 2017 FY | 16.84 Billion USD | 17.74% |
| 2017 Q4 | 17.33 Billion USD | 335.91% |
| 2017 Q1 | 4.78 Billion USD | 26.05% |
| 2016 Q4 | 3.79 Billion USD | 0.0% |
| 2016 Q2 | 3.79 Billion USD | 0.0% |
| 2016 Q1 | 3.79 Billion USD | -0.03% |
| 2016 Q3 | 3.79 Billion USD | -0.03% |
| 2016 FY | 14.3 Billion USD | 277.04% |
| 2015 Q2 | 3.82 Billion USD | -0.03% |
| 2015 FY | 3.79 Billion USD | -0.81% |
| 2015 Q4 | 3.79 Billion USD | -0.73% |
| 2015 Q3 | 3.82 Billion USD | -0.03% |
| 2015 Q1 | 3.82 Billion USD | -0.03% |
| 2014 Q2 | 2.59 Billion USD | -0.12% |
| 2014 Q3 | 3.82 Billion USD | 47.44% |
| 2014 Q4 | 3.82 Billion USD | -0.03% |
| 2014 Q1 | 2.59 Billion USD | -0.08% |
| 2014 FY | 3.82 Billion USD | 47.12% |
| 2013 FY | 2.6 Billion USD | -0.42% |
| 2013 Q1 | 2.6 Billion USD | -0.11% |
| 2013 Q2 | 2.6 Billion USD | -0.08% |
| 2013 Q3 | 2.6 Billion USD | -0.12% |
| 2013 Q4 | 2.6 Billion USD | -0.12% |
| 2012 Q3 | 1.61 Billion USD | -0.12% |
| 2012 Q4 | 2.61 Billion USD | 61.57% |
| 2012 Q2 | 1.61 Billion USD | 0.0% |
| 2012 FY | 2.61 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -25600.458% |
| Accuray Incorporated | 423.54 Million USD | -7159.475% |
| Align Technology, Inc. | 2.45 Billion USD | -1153.247% |
| Elevance Health Inc. | 69.52 Billion USD | 55.774% |
| AxoGen, Inc. | 101.16 Million USD | -30293.824% |
| Boston Scientific Corporation | 15.6 Billion USD | -97.02% |
| CVS Health Corporation | 173.09 Billion USD | 82.237% |
| Cardinal Health, Inc. | 48.33 Billion USD | 36.385% |
| Centene Corporation | 58.68 Billion USD | 47.607% |
| DaVita Inc. | 14.87 Billion USD | -106.687% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 44.249% |
| Hologic, Inc. | 4.02 Billion USD | -663.711% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -1631.84% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -248.029% |
| Masimo Corporation | 1.67 Billion USD | -1733.781% |
| McKesson Corporation | 69.04 Billion USD | 55.466% |
| Patterson Companies, Inc. | 1.89 Billion USD | -1522.533% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -304.353% |
| ResMed Inc. | 2 Billion USD | -1430.957% |
| Henry Schein, Inc. | 5.42 Billion USD | -467.288% |
| Teladoc Health, Inc. | 2.06 Billion USD | -1388.025% |
| Universal Health Services, Inc. | 8.15 Billion USD | -277.035% |
| Veeva Systems Inc. | 1.26 Billion USD | -2328.489% |
| Baxter International Inc. | 19.8 Billion USD | -55.225% |
| Becton, Dickinson and Company | 26.98 Billion USD | -13.945% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -1404.109% |
| Danaher Corporation | 30.99 Billion USD | 0.81% |
| Stryker Corporation | 21.31 Billion USD | -44.223% |
| Medtronic plc | 39.56 Billion USD | 22.28% |